Intrinsic Alpha

CVS Health Corporation

NYSE:CVS

Medical - Healthcare Plans

Healthcare
$80.84 -0.59%

-$0.59 today

Market cap
$103.43B
Beta
0.62
P/E (TTM)
42.8
EPS (TTM)
$2.30
Dividend yield
2.70%
52W Low $58.50High $102.77

Volume 10.71M

Average 8.19M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$10.64B

FY 2025 · Annual

+16.8% YoY

Investing Cash Flow

-$5.87B

FY 2025 · Annual

Financing Cash Flow

-$4.94B

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income7.99B4.33B8.37B4.59B1.73B
Depreciation & Amortization4.49B4.22B4.37B4.6B4.61B
Deferred Income Tax(402M)(2.03B)(676M)(572M)102M
Stock-Based Compensation484M447M588M540M535M
Change in Working Capital3.86B6.82B15M109M(1.47B)
Accounts Receivables(2.7B)(2.97B)(6.26B)(1.3B)(3.5B)
Inventory735M(1.44B)1.23B(102M)(1.27B)
Accounts Payables2.9B4.26B3.62B2.34B3.86B
Other Working Capital2.93B6.96B1.42B(823M)(564M)
Other Non-Cash Items1.85B2.39B765M(153M)5.14B
Operating Cash Flow18.27B16.18B13.43B9.11B10.64B
Capital Expenditures(2.52B)(2.73B)(3.03B)(2.78B)(2.83B)
Acquisitions (Net)(146M)(1.39B)(16.61B)(95M)(436M)
Purchases of Investments(9.96B)(7.75B)(9.04B)(15.19B)(15.01B)
Sales of Investments7.25B6.73B7.73B10.35B12.38B
Other Investing Activities122M85M68M101M26M
Investing Cash Flow(5.26B)(5.05B)(20.89B)(7.61B)(5.87B)
Debt Repayment(9.27B)(4.21B)7.93B5.06B(3.9B)
Common Stock Issued0000394M
Common Stock Repurchased0(3.5B)(2.01B)(3.02B)0
Dividends Paid(2.63B)(2.91B)(3.13B)(3.37B)(3.4B)
Other Financing Activities536M102M(105M)202M1.96B
Financing Cash Flow(11.36B)(10.52B)2.68B(1.14B)(4.94B)
Effect of Forex Changes00000
Net Change in Cash1.65B614M(4.78B)359M(172M)
Free Cash Flow15.75B13.45B10.4B6.33B7.81B

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$1.7B
+ D&A$4.6B
+ Stock-Based Comp$535.0M
+ Deferred Tax$102.0M
- Working Capital-$1.5B
+ Other Non-Cash$5.1B
= Operating Cash Flow$10.6B
- Capex-$2.8B
= Free Cash Flow$7.8B

Analysis

FY2025 free cash flow is $7.8B. FCF conversion is 451.8% of net income. Operating cash flow was $10.6B, with capex of -$2.8B. The largest bridge item is Other Non-Cash at $5.1B.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 6, 2026
13F-HR13F-HR filingNov 5, 2026
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
8-KCurrent reportNov 4, 2026

Does CVS generate free cash flow?

CVS Health Corporation (CVS) generated $7.81B of free cash flow in fiscal 2025.

How much operating cash flow does CVS produce?

Operating cash flow was $10.64B, before capital expenditures of $2.83B.